O	0	7	Summary	Summary	NNP	B-NP

O	8	13	Kindt	Kindt	NNP	B-NP
O	14	16	et	et	FW	I-NP
O	17	19	al	al	FW	I-NP
O	19	20	.	.	.	I-NP
O	20	21	1	1	CD	I-NP
O	22	31	published	publish	VBD	B-VP
O	32	33	a	a	DT	B-NP
O	34	40	report	report	NN	I-NP
O	41	49	entitled	entitle	VBD	B-VP
O	50	51	"	"	``	O
B-Multi-tissue_structure	51	61	Intestinal	Intestinal	JJ	B-NP
O	62	68	immune	immune	JJ	I-NP
O	69	79	activation	activation	NN	I-NP
O	80	82	in	in	IN	B-PP
O	83	91	presumed	presume	VBN	B-NP
O	92	96	post	post	AFX	I-NP
O	96	97	-	-	HYPH	I-NP
O	97	107	infectious	infectious	JJ	I-NP
O	108	118	functional	functional	JJ	I-NP
O	119	128	syspepsia	syspepsia	NN	I-NP
O	128	129	"	"	''	O
O	130	132	in	in	IN	B-PP
O	133	136	the	the	DT	B-NP
O	137	143	August	August	NNP	I-NP
O	144	149	issue	issue	NN	I-NP
O	150	152	of	of	IN	B-PP
O	153	174	Neurogastroenterology	Neurogastroenterology	NN	B-NP
O	175	178	and	and	CC	I-NP
O	179	187	Motility	Motility	NN	I-NP
O	188	190	in	in	IN	B-PP
O	191	195	2009	2009	CD	B-NP
O	195	196	.	.	.	O

O	197	199	By	By	IN	B-PP
O	200	209	comparing	compare	VBG	B-VP
O	210	213	the	the	DT	B-NP
O	214	219	signs	sign	NNS	I-NP
O	220	222	of	of	IN	B-PP
O	223	235	inflammation	inflammation	NN	B-NP
O	236	239	and	and	CC	O
O	240	243	the	the	DT	B-NP
O	244	250	degree	degree	NN	I-NP
O	251	253	of	of	IN	B-PP
O	254	265	hyperplasia	hyperplasia	NN	B-NP
O	266	268	of	of	IN	B-PP
O	269	272	the	the	DT	B-NP
B-Cell	273	289	enterochromaffin	enterochromaffin	NN	I-NP
I-Cell	290	295	cells	cell	NNS	I-NP
O	296	297	(	(	(	O
B-Cell	297	299	EC	EC	NN	B-NP
O	299	300	)	)	)	O
O	301	303	in	in	IN	B-PP
B-Multi-tissue_structure	304	312	duodenal	duodenal	JJ	B-NP
I-Multi-tissue_structure	313	321	biopsies	biopsy	NNS	I-NP
O	322	330	obtained	obtain	VBN	B-VP
O	331	335	from	from	IN	B-PP
O	336	344	patients	patient	NNS	B-NP
O	345	349	with	with	IN	B-PP
O	350	358	presumed	presume	VBN	B-VP
O	359	363	post	post	AFX	B-NP
O	363	364	-	-	HYPH	I-NP
O	364	374	infectious	infectious	JJ	I-NP
O	375	385	functional	functional	JJ	I-NP
O	386	395	dyspepsia	dyspepsia	NN	I-NP
O	396	397	(	(	(	O
O	397	399	PI	PI	NN	B-NP
O	399	400	-	-	HYPH	B-NP
O	400	402	FD	FD	NN	I-NP
O	402	403	)	)	)	O
O	404	407	and	and	CC	O
O	408	419	unspecified	unspecified	JJ	B-NP
O	419	420	-	-	HYPH	I-NP
O	420	425	onset	onset	NN	I-NP
O	426	436	functional	functional	JJ	I-NP
O	437	446	dyspepsia	dyspepsia	NN	I-NP
O	447	448	(	(	(	O
O	448	449	U	U	NN	B-NP
O	449	450	-	-	HYPH	B-NP
O	450	452	FD	FD	NN	I-NP
O	452	453	)	)	)	O
O	453	454	,	,	,	O
O	455	459	they	they	PRP	B-NP
O	460	466	showed	show	VBD	B-VP
O	467	471	that	that	IN	B-SBAR
O	472	474	PI	PI	NN	B-NP
O	474	475	-	-	HYPH	B-NP
O	475	477	FD	FD	NN	I-NP
O	478	480	is	be	VBZ	B-VP
O	481	491	associated	associate	VBN	I-VP
O	492	496	with	with	IN	B-PP
O	497	508	persistence	persistence	NN	B-NP
O	509	511	of	of	IN	B-PP
O	512	517	focal	focal	JJ	B-NP
B-Cell	518	519	T	T	NN	I-NP
I-Cell	519	520	-	-	HYPH	B-NP
I-Cell	520	524	cell	cell	NN	I-NP
O	525	535	aggregates	aggregate	NNS	I-NP
O	535	536	,	,	,	O
O	537	545	decrease	decrease	NN	B-NP
O	546	548	in	in	IN	B-PP
B-Cell	549	552	CD4	CD4	NN	B-NP
I-Cell	552	553	+	+	SYM	B-NP
I-Cell	554	559	cells	cell	NNS	I-NP
O	560	563	and	and	CC	O
O	564	573	increased	increase	VBN	B-NP
B-Cell	574	584	macrophage	macrophage	NN	I-NP
O	585	591	counts	count	NNS	I-NP
O	592	603	surrounding	surround	VBG	B-VP
O	604	607	the	the	DT	B-NP
B-Multi-tissue_structure	608	614	crypts	crypt	NNS	I-NP
O	614	615	,	,	,	O
O	616	623	without	without	IN	B-PP
O	624	627	any	any	DT	B-NP
O	628	639	significant	significant	JJ	I-NP
O	640	651	differences	difference	NNS	I-NP
O	652	654	in	in	IN	B-PP
O	655	658	the	the	DT	B-NP
O	659	666	numbers	number	NNS	I-NP
O	667	669	of	of	IN	B-PP
B-Cell	670	672	EC	EC	NN	B-NP
O	673	675	or	or	CC	O
B-Cell	676	688	chromogranin	chromogranin	NN	B-NP
I-Cell	689	690	A	A	NN	I-NP
I-Cell	691	692	(	(	(	O
I-Cell	692	694	CA	CA	NN	B-NP
I-Cell	694	695	)	)	)	O
I-Cell	695	696	-	-	HYPH	B-NP
I-Cell	696	704	positive	positive	JJ	I-NP
I-Cell	705	710	cells	cell	NNS	I-NP
O	711	712	(	(	(	O
B-Cell	712	716	mast	mast	NN	B-NP
I-Cell	717	722	cells	cell	NNS	I-NP
O	722	723	)	)	)	O
O	723	724	.	.	.	O

O	725	729	This	This	DT	B-NP
O	730	737	finding	finding	NN	I-NP
O	738	741	may	may	MD	B-VP
O	742	750	indicate	indicate	VB	I-VP
O	751	759	impaired	impaired	JJ	B-NP
O	760	767	ability	ability	NN	I-NP
O	768	770	of	of	IN	B-PP
O	771	774	the	the	DT	B-NP
B-Anatomical_system	775	781	immune	immune	JJ	I-NP
I-Anatomical_system	782	788	system	system	NN	I-NP
O	789	791	in	in	IN	B-PP
O	792	797	these	these	DT	B-NP
O	798	803	cases	case	NNS	I-NP
O	804	806	to	to	TO	B-VP
O	807	816	terminate	terminate	VB	I-VP
O	817	820	the	the	DT	B-NP
O	821	833	inflammatory	inflammatory	JJ	I-NP
O	834	842	response	response	NN	I-NP
O	843	848	after	after	IN	B-PP
O	849	851	an	an	DT	B-NP
O	852	857	acute	acute	JJ	I-NP
O	858	864	insult	insult	NN	I-NP
O	864	865	.	.	.	O

